Skip to main content
. 2020;11(3):101–106.

Table 1.

Patients’ demographics

Patient Age/Sex Native Disease LTx/Days post- CLAD CRD Grade
1 72/M UIP SLT/1853 CLAD/BOS 2 4
2 56/M CF BLT/7212 CLAD/BOS 3 4
3 75/M HP SLT/1262 CLAD/RAS 2 3B
4 68/F CPFE SLT/2104 CLAD/BOS 1 4
5 72/M UIP SLT/1710 CLAD/RAS 1 5
6 38/M GVHD BLT/3660 CLAD/RAS 2 4
7 68/M COPD SLT/775 CLAD/RAS 2 4
8 63/M UIP BLT/1952 CLAD/RAS 3 4
9 67/M HP SLT/808 CLAD/BOS 2 3B

UIP: Usual interstitial pneumonitis; COPD: Chronic obstructive lung disease; CF: Cystic fibrosis; HP: Chronic hypersensitivity pneumonitis; CPFE: Combined pulmonary fibrosis + emphysema; GVHD: Chronic graft vs. host disease; LT: Single lung transplant; BLT: Bilateral lung transplant; CLAD: Chronic lung allograft dysfunction; BOS: Bronchiolitis obliterans syndrome; RAS: Restrictive allograft syndrome